This medication is taken by injection.
Extavia® and Betaseron® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).
Extavia and Betaseron are approved by the FDA for the treatment of relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).
Click here to read the Extavia Prescribing Information for healthcare professionals.
Click here to read the Extavia Medication Guide for patients.
Click here to read the Betaseron Prescribing Information for healthcare professionals.
Click here to read the Betaseron Medication Guide for patients.
Extavia Go Program
Financial Assistance Program
EXTAVIA GO PROGRAM